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Abstract:
In eukaryotic translation initiation, eIF2⋅GTP/Met- tRNAiMet ternary
complex (TC) interacts with eIF3/eIF1/eIF5 complex to form the multifactor
complex (MFC), while eIF2·GDP associates with eIF2B for guanine nucleotide
exchange. Gcn2p phosphorylates eIF2 to inhibit eIF2B. Here we evaluate the
abundance of eIFs and their pre-initiation intermediate complexes in gcn2
deletion mutant grown under different conditions. We show that ribosomes
are three times as abundant as eIF1, eIF2 and eIF5, while eIF3 is half as
abundant as the latter three and hence, the limiting component in MFC
formation. By quantitative immunoprecipitation, we estimate that ∼15% of
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be
further copied/distributed or hosted elsewhere without the express permission from Elsevier.

2

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

the cellular eIF2 is found in TC during rapid growth in a complex rich medium.
Most of the TC is found in MFC, and important, ∼40% of the total eIF2 is
associated with eIF5 but lacks tRNAiMet. When the gcn2Δ mutant grows less
rapidly in a defined complete medium, TC abundance increases 3-fold without
altering the abundance of each individual factor. Interestingly, the TC
increase is suppressed by eIF5 overexpression and Gcn2p expression. Thus,
eIF2B-catalyzed TC formation appears to be fine-tuned by eIF2
phosphorylation and the novel eIF2/eIF5 complex lacking tRNA iMet.
Abbreviations used:

eIF, eukaryotic initiation factor; TC, ternary complex; GAP, GTPase activating protein; G
protein, guanine nucleotide binding protein; GEF, guanine nucleotide exchange factor;
CTD, carboxyl-terminal domain; NTD, amino-terminal domain; YPD, yeast-extract
peptone dextrose (medium); SC, synthetic defined complete (medium); MFC,
multifactor complex; AA-box, acidic and aromatic amino acid box; PBS, phosphatebuffered saline; GST, glutathione S-transferase; FH, FLAG-epitope and polyhistidine
double affinity tag; WCE, whole cell extract
Keywords: yeast, eIF, proteomics, nutritional control, translation initiation protein

complex.

Introduction
The translation initiation reaction in eukaryotes starts with the
dissociation of 80S ribosome into small 40S and large 60S ribosomal
subunits, mediated by eukaryotic initiation factors (eIF) 1A and 3. The
sequential binding of the eIF2⋅GTP/Met- tRNAiMet ternary complex (TC)
and eIF4F/m7G-capped mRNA complex to the 40S subunit constitutes
formation of the 43S and 48S preinitiation complexes, respectively.
The multisubunit factor eIF3, eIF5 and eIF1 promote these assembly
processes by binding directly or indirectly to the 40S subunit forming
the 48S preinitiation complex (for reviews, see 1; 2). The 48S complex
searches for the first AUG codon in the mRNA with the help of eIF1,
eIF1A, the RNA helicase eIF4A and its cofactor eIF4B. Correct base
pairing between the Met- tRNAiMet anticodon and the AUG codon
triggers the hydrolysis of GTP bound to eIF2. This is stimulated by a
GTPase activating protein eIF5 3 and the resulting phosphate release
is coupled to eIF1 dissociation 4. These events lead to dissociation of
eIF2·GDP and other pre-assembled eIFs, making it possible for the
40S initiation complex to join with the 60S subunit, through the action
of a second guanine nucleotide binding (G) protein eIF5B. Polypeptide
Neuroscience Letters, Vol. 423, No. 1 (August 2015): pg. 18-23. DOI. This article is © Elsevier and permission has been
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be
further copied/distributed or hosted elsewhere without the express permission from Elsevier.

3

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

chain elongation starts from the methionine linked to the 80S initiation
complex. Because only the GTP-form of eIF2 is capable of binding MettRNAiMet to form TC, GDP-bound eIF2 must be recycled to replenish
eIF2·GTP by the guanine nucleotide exchange factor (GEF) eIF2B1; 2.
The reactions described above are mediated by a series of
complex assembly processes. eIF2 TC interacts with eIF1, eIF3 and
eIF5 to form the stoichiometric multifactor complex (MFC) 5. The Cterminal HEAT domain of eIF5, with the conserved acidic and aromatic
amino acid (AA)-boxes 6; 7, serves as an important core of MFC by
binding concurrently to eIF1 and the N-terminal domains (NTDs) of
eIF2β and eIF3c (Reviewed in 2). The tif5-7A mutation altering the
eIF5 AA-box 2 disrupts the interaction between eIF2 and eIF3 and
confers temperature-sensitivity to yeast cell growth. This phenotype is
suppressible by the co-overexpression of all three eIF2 subunits and
tRNAiMet 5; 8. These results demonstrate that the eIF5-CTD stabilizes a
critical bridge between eIF2 and eIF3, the two major components of
43S pre-initiation complex.
The interaction between eIF2·GDP and its nucleotide exchange
factor eIF2B is also complex;eIF2B is made of five subunits with stable
binding sites for the α and β subunits of eIF2, located at eIF2Bα/β/δ
regulator subcomplex 9 and the C-terminal end of the minimal
catalytic eIF2Bε-CTD segment 10, respectively. In addition, the
eIF2Bε-CTD segment interacts with eIF2γ 11. The complexity of
subunit interactions is in part due to the requirement for translational
control mediated by eIF2 phosphorylation. From yeast to humans,
eIF2 phosphorylation converts eIF2 from a substrate into a competitive
inhibitor of eIF2B, thereby decreasing TC abundance. This effect
inhibits general translation and paradoxically induces translation of
GCN4 (in yeast) and ATF4 (in mammals) mRNAs encoding
transcription factors by a mechanism involving upstream ORFs
(uORFs) present in the 5′ leader region of each mRNA 12. Third,
mRNA circularization is mediated through eIF4E bound to the 5′ cap
and the poly(A) binding protein (PABP) bound to the poly(A) tail.
eIF4E, PABP, and eIF4A all bind to the eIF4G subunit of eIF4F and
enhances recruitment of the 40S subunit 13.
Proteomic approaches using yeast S. cerevisiae as a model
eukaryote have generated numerous sets of data concerning protein
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abundance and protein-protein interactions. In a founding study by
Futcher et al., 2D gel electrophoresis was used to separate ∼1200
different yeast proteins, of which 148 were identified by mass
spectrometry. This study determined that the amounts of a large
ribosomal protein Rpp0, eIF3b, and eIF4A are 277 × 103, 12 × 103,
and 233 × 103 copies per cell, respectively 14. In a more
comprehensive study, Ghaemmaghami et al. fused 98% of the 6234
gene products in yeast with a C-terminal TAP sequence and measured
the level of the fusions by anti-CBP antibodies 15. Their study
indicated relative cellular abundances of 19 separate eIF polypeptides.
In a further independent study, the McCarthy group measured the
amount of eIF- 1, 1A, 2α, 2γ, 2Bα, 3g, 4A, 4B, 4E, and 4G1 in yeast
whole cell extract (WCE) by immunoblotting with polyclonal antibodies
raised against each protein and by using purified proteins as standards
16. The comparison of the data obtained from the latter two studies
showed a wide variation in eIF abundance estimates. In addition, the
available yeast proteome data is unlinked to ribosome levels, except
via the data from Futcher et al.14. This is partly because in
Ghaemmaghami's approach, the C-terminal tagging of most ribosomal
proteins was lethal. Furthermore, tRNAiMet abundance has not been
determined in direct comparison with eIFs.
Another goal of proteomics is to study interactions between all
the proteins in the proteome. Large-scale approaches have used
systematic two-hybrid and protein array interaction assays 17 as well
as mass-spectrometrical identification of proteins associated with
affinity-purified TAP-tagged proteins 18; 19. A challenge in these
approaches is to know how protein phosphorylation or ligand-binding
regulates the formation and composition of different complexes 20;
21. The translation initiation pathway involves several well-defined
protein complexes whose formation is controlled by phosphorylation,
bound nucleotides or RNA components. Without precise abundance
information for co-purifying partners present in multiple complexes, it
is difficult to partition proportions of each factor into each of the
complexes formed. Thus in this study, we have extended the
proteomics data relevant to translation initiation and determined the
abundances of eIF complexes with a quantitative immunoprecipitation
method. For this work, we have focused on the TC made of eIF2, GTP
and Met- tRNAiMet and the MFC containing eIF1, eIF3, eIF5, and TC. We
found that only a portion of eIF2/eIF5 complexes is a part of MFC,
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while the majority of the rest are not bound to Met- tRNAiMet. We
established a method to measure cellular TC abundance and observed
that dynamic changes in its steady-state levels are associated with
growth medium composition and Gcn2p expression. Our results extend
the recently proposed role for the eIF2/eIF5 complex lacking MettRNAiMet in antagonizing the eIF2B activity 22, and suggest that
alternative ways to control eIF2 TC abundance exist.

Results
The cellular level of eIFs in Saccharomyces cerevisiae
We compared the eIF levels determined previously by the
whole-genome TAP-tagging approach of Ghaemmaghami et al. 15, as
well as the levels determined by von der Haar et al. using
immunoblotting of cell extracts with polypeptide-specific polyclonal
antibodies and purified eIF samples as standards 16 (Table I, columns
3 and 4). These comparisons revealed both that large variations were
apparent in the estimated abundances of the factors assessed and that
neither dataset was comprehensive. We therefore decided to reevaluate the cellular abundance of various factors and extend the
analysis to include additional factors, initiator tRNA and ribosomal
protein levels not included in the previous studies. For this purpose,
we employed a series of yeast strains encoding FLAG- or HA-epitope
tagged versions of eIFs- 1, 2β 2Bγ, 3c, 3i, 4G1, 4G2, 5 or the large
ribosomal protein Rpl25p as the sole source of these factors. These
strains are listed in Table II. After the early exponential growth (to
A600=1.5-2.0) in the nutrient-rich medium YPD, WCEs prepared by a
mild glass beads disruption were used for immunoblotting. This
method of WCE preparation is routinely used to analyze proteinprotein interactions (see below) and, with a minor modification, to
produce a cell-free translation system 23.
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Table I

Comparison of eIF levels determined in this study with those

reported by Ghaemmaghami et al. 15 and Von der Haar et al. 16
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Table II

Yeast S. cerevisiae strains employed for eIF and complex level

determination

As shown in Fig. 1A and B, fixed amounts of WCE from each
strain were separated by SDS-PAGE and subjected to immunoblotting
with anti-FLAG or anti-HA antibodies. The densities of FLAG-tagged eIF
bands were quantified using NIH Image software, and presented as
values relative to the level of eIF5-FL in row 1 of the tables below the
immunoblotting patterns in Fig. 1A. Likewise, the densities of HAtagged eIF bands were quantified and presented as values relative to
the level of eIF3i-3HA (row 1 of the table in Fig. 1B). To normalize for
any effects of epitope-tagging on the expression level of each eIF, we
probed the same membrane as used for anti-FLAG or –HA with
antibodies raised against the relevant unmodified protein (see Fig. S1
for a representative example) and found that the presence of the tag
did not affect protein abundance (row 2 of the tables in Fig. 1A-B) for
all proteins assessed except for FL-eIF1 that was expressed from a
stronger GPD promoter to increase its detection (see below; all other
tagged eIFs were expressed from the natural promoter except for HAeIF4G1 in YAS2136. HA-eIF4G1 in this strain is expressed under the
TIF4632 promoter, but we confirmed that its abundance is identical to
that of untagged eIF4G1 in the other strains). Note that the strains
expressing each tagged allele have different genetic backgrounds
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(Table II). This indicates that differences between strains in commonly
used genetic markers and the presence or absence of GCN2 in
particular, does not affect eIF protein abundance. Because amino acid
composition of the measured protein may change its transfer efficiency
to the blotting membrane (see Fig. 2), we then normalized the
abundance values for the immuno-detection efficiency (row 3 of the
table in Fig. 1A-B). After these normalizations, the cellular levels of
eIFs and Rpl25p, relative to that of eIF5, were determined and these
values are summarized in the bottom row of the tables in Fig. 1A and
B.

Fig. 1

Determination of cellular eIF levels.

(A) Example of quantitative detection of indicated FLAG-tagged proteins in WCE from
yeast strains by immunoblotting with anti-FLAG antibodies. Table summarizes
densitometry analysis to determine the expression level relative to eIF5 (set to
100%). FLAG antibody signal density was controlled by the following two factors: (1)
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Relative expression level of the epitope-tagged protein, compared to the endogenous
level of the cognate protein. This was determined by immunoblotting with antibodies
raised against each protein (see Fig. S1). (2) Relative detection efficiency of the FLAGtagged protein, compared to that of eIF5-FL, as determined by anti-FLAG antibodies.
(See Fig. 2 below). N. T., not tested due to technical problems or lack of antibodies.
(B) Determination of HA-tagged eIF levels. Analysis was done as in panel A but with
indicated HA-tagged yeast strains and anti-HA antibodies. (C) Data from Ref. 16 and
Ref. 15 plotted against data from this study as empty squares and filled diamonds,
respectively. Dotted arrows indicate values for individual eIFs. Grey line indicates the
linear regression with the data from 16. For the data from 15, the eIF3 and eIF2 levels
were averaged from the values for the a/b/c- and α/γ– subunits, respectively. The
eIF2B level was averaged from the values for α, β, γ and δ subunits.

Fig. 2

Transfer and detection efficiency of purified FLAG-eIFs.

Indicated amounts of purified proteins were subjected to SDS-PAGE, followed by
Coomassie Blue staining (panel A, lanes 1-10) or immunoblotting with anti-FLAG
antibodies (panel A, lanes 11-27; panel B). To increase the accuracy of measuring the
intensity of anti-FLAG detection per pmol of FLAG-proteins, we ran two separate SDS-
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PAGE gels at the same time, one loaded with indicated amounts of purified proteins,
and the other loaded with four times more of the same proteins. The former was
subjected to immunoblotting as shown, and the latter was stained with Coomassie
Blue to determine the protein concentrations of the samples in comparison with the
amount of eIF5-FL on the same gel. The eIF5-FL sample concentration was determined
by comparing to known amounts of BSA, as shown in Panel A, lanes 2-5. The results
indicate that the detection efficiency for all expect eIF1 (as in C) and eIF2Bγ is
identical. That for eIF2γ is 2.0, because of two copies of the FLAG epitope. (C) The
density of anti-FLAG reactivity was plotted against molar amounts of FL-eIF1 or eIF5FL in each lane.

The relative expression value indicated for eIF1 deviated most
from the original density value (table in Fig. 1A). This is because: (i)
FL-eIF1 expression was increased by 4-fold compared to the
endogenous eIF1 due to using a stronger GPD promoter (row 2) and
(ii) FL-eIF1 was detected 24 times less effectively than eIF5-FL (Fig.
1A, table row 3, and Fig. 2B-C). The second point was determined by
anti-FLAG immunoblotting with known amounts of purified
recombinant FL-eIF1 and eIF5-FL, as shown in Fig. 2B. In contrast, the
efficiency of detection was indistinguishable between recombinant
forms of FL-eIF2β, eIF3i-FL, Rpl25-FL, eIF5-FL and eIF2Bγ-2FL (the
latter from eIF2B purified from yeast, Fig. 2A). Our data are in
agreement with previous observations 15 that most yeast proteins
visible by Coommassie Blue staining in SDS-PAGE are transferred to
nylon or nitrocellulose membranes at nearly identical efficiency (data
not shown). Thus, eIF1 is clearly an exception. We suspect that altered
transfer or detection efficiencies for a minor subset of the proteome
produce a limitation for systematically determining the levels of the
proteins encoded in the genome.
Because we obtained abundance values relative to total eIF5
(Fig. 1A and B), we converted them into absolute copies per cell, by
comparing our relative ribosome abundance of 298% of total eIF5 with
the previously determined ribosome abundance of 200,000 copies per
cell 24 (Fig. 1A). The calculated absolute abundance values are
presented in Table I, column 5. To establish a limiting factor in TC
formation, we also determined the cellular abundance of tRNAiMet and
directly compared it with the cellular level of eIF2. For this purpose,
we used known amounts of purified eIF2 and tRNAiMet as standards on
Western and Northern blots and analyzed them side-by-side with the
same from yeast WCE. We estimated that the level of tRNAiMet is ten
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times higher (640,000 copies/cell) than that of eIF2 (63,000
copies/cell), indicating that eIF2 is the limiting component in forming
ternary complexes in vivo.
Our data indicates that ribosomes are three times as abundant
as the multi-factor complex (MFC) components eIF1, eIF2 and eIF5
(81,000, 63,000, and 67,000 copies/cell, respectively; Table I, column
5). eIF3 (32,000-34,000 copies/cell) is present at half the levels of
other MFC components; thus, eIF3 is the limiting component in the
formation of MFC. Met- tRNAiMet is in large excess over eIF2 (provided
that a significant proportion of tRNAiMet is aminoacylated; see below
Fig. 3C), whereas eIF2B (5000 copies/cell) is the least abundant factor
we measured. eIF2Bγ is present at only ∼7% of the level of eIF2.
These observations agree with the idea that GTP binding to eIF2 is the
limiting step in forming TC. When plotted against the values obtained
by von der Haar et al. 16, our data of eIF abundance have almost a
linear correlation with theirs, with the slope of the linear regression
being 2.94 (Fig. 1C). We do not know why the values from von der
Haar et al. are three times higher than those we obtained in this study
(Table I, columns 4 and 5). We note, however, that the authors did
not measure ribosome or ribosomal protein abundance by their
methods, so their values are in theory unlinked to the ribosome level,
a commonly used standard. In conclusion, our data largely confirmed
the relative (but not the absolute) abundance values determined by
von der Haar et al.16, and importantly, add new information about the
level of eIF5 and (Met-) tRNAiMet, and the relationship between
individual initiation factor abundance and ribosome abundance (see
below Fig. 7).
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Fig. 3

Determination of TC and eIF assembly intermediate levels in vivo and

identification of a novel eIF2/eIF5 complex lacking tRNAiMet.
(A) 1 mg of WCE prepared from KAY17 (Control), KAY128 (TIF5), and KAY284 (tif57A) was used for anti-FLAG immunoprecipitation, and 80 % (top gel) and 20 %
(bottom gels) of the precipitated fractions (lanes under IP) were analyzed by northern
and western blotting, respectively, with 2% in-put amount (lanes under In-put) and
purified tRNAiMet and eIF2 as the standard (not shown), as described under Materials
and Methods. The molar amounts (per 1 mg WCE) of precipitated components,
calculated in comparison with the band densities of purified components, are listed
below each panel. (B) TC and MFC levels. % of tRNAiMet - or eIF3-bound eIF2
compared to total eIF2, observed in KAY128 (WT) and KAY284 (7A), is shown by bars
with SD in lines. (C) Confirmation of intact Met- tRNAiMet during TC level
determination. Our prep; the RNA samples were isolated from the in-put WCE sample
under acidic conditions and analyzed by the acidic urea PAGE and the detection using
a probe for tRNAiMet, all as described under Materials and Methods. Control; intact
aminoacyl tRNA sample was prepared directly from yeast and analyzed similarly. +;
fully deacylated by incubating in 2 M Tris-HCl (pH 8.0) at 37°C, 30 min. -; no alkaline
treatment. (D) and (E) Analyses of eIF complexes by sucrose gradient-velocity
sedimentation. KAY25 (FL-SUI3) was grown in YPD at 30°C, treated with
cycloheximide for 5 min, and then harvested for preparation of WCE, as described
previously 54. 25 A260 units of the WCE were fractionated on 5-45% sucrose gradients
by centrifugation at 39000 rpm for 2 h. (D) Top panel, A254 profile indicating the
positions of ribosomal species. A half of the first 5 fractions was precipitated with
ethanol and analyzed by SDS-PAGE and immunoblotting with antibodies indicated to
the right. (E) The reminder of the fractions was incubated with anti-FLAG affinity resin
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(Sigma) for 30 min, followed by washing 4 times. eIFs in ethanol- or immunoprecipitated fractions were analyzed for immunoblotting together on the same gel, to
know the relative amount of FL-eIF2 precipitated. In, 1% of the input amount.

Fig. 7

The abundance model of eIF2 assembly reactions in S. cerevisiae

cells growing in the YPD medium.
The right column describes a sequence of eIF2 reactions from the previous round of
initiation (Initiation) to the formation of 43S complex (MFC ≃ 43S) for the new round
of initiation. The levels of eIF2 intermediate complexes determined in this study were
translated into absolute levels, based on the ribosomal level of 200 000 copies/cell 24
and presented in italicized beside the relevant complexes. The following values were
used for calculation: Total eIF2 level, 63,000 copies/cell. Total eIF2/eIF5 complex, TC
and MFC level, 54%, 15%, and 7.5% of total eIF2, respectively (from Fig. 3A, Fig. 5A
and other independent experiments). Total TC/eIF5 complex level, 22% of eIF2 bound
to eIF5 (from Fig. 5D and other independent experiments). The left column depicts the
dissociation of the ribosome. The level (italicized) and percentage (in parentheses) of
the ribosome in each stage are presented. Although we reason that the eIF2/eIF5
complex lacking tRNAiMet is bound to GDP, this needs to be demonstrated in the future.
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Determination of eIF2 TC and MFC levels in vivo
Having established abundances of individual factors, we wished
to determine what proportions were present in different complexes
that form pre-initation factor complex intermediates. To determine TC
level, we immunoprecipitated FL-eIF2 from a gcn2Δ strain KAY128
encoding FL-eIF2β as the sole source of eIF2β and determined the
amount of eIF2 and coprecipitating tRNAiMet by Western and Northern
blotting, respectively. Known amounts of each purified component
were included as standards (not shown in Fig. 3A). Analysis of
supernatant fractions revealed that there is nearly a full recovery of
FL-eIF2 in the pellet fractions, suggesting that FL-eIF2 complexes are
stable during the course of these experiments (data not shown). Fig.
3A shows that 2.5 pmol FL-eIF2 coprecipitated with 0.42 pmol of
tRNAiMet, indicating that only 16% of eIF2 is tightly associated with
tRNAiMet. This is likely to be in the form of the ternary complex (TC).
From this and several other independent experiments, we conclude
that the cellular TC level represents 13.4% ± 2% of the total cellular
eIF2 (Fig. 3B, column 1).
These data also indicate that the amounts of eIF3 (0.3 pmol),
eIF1 (0.4 pmol) and tRNAiMet (0.42 pmol) that coprecipitating with FLeIF2 are roughly equivalent (Fig. 3A), suggesting that tRNAiMet binding
to FL-eIF2 occurs in the context of the multifactor complex under
these growth conditions. Because interaction between eIF2 and eIF3
depends on an intact eIF5 C-terminal domain (CTD) 5; 25, the
presence of eIF3 in complex with eIF2 is the hallmark of MFC (Fig. 3A,
fourth panel). Fig. 3B shows that the level of MFC, determined by the
ratio of precipitated eIF3 to eIF2, is 7.6 ± 2% of total eIF2. Together
with the cellular TC levels calculated above, these results suggest that
once TC is formed it is rapidly converted into MFC.
The methionyl moiety of Met- tRNAiMet directly binds eIF2γ and
this interaction promotes TC formation 2. Thus, deacylation of MettRNAiMet during WCE preparation could potentially decrease its affinity
for eIF2, and hence reduce the yield of tRNAiMet t in the FL-eIF2
complex. To assess if this was a problem with our assays, we analyzed
the ratio of aminoacylated:deacylated tRNAiMet in our WCE preparations
by extracting total RNA under acidic conditions, and by using acidic
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urea PAGE to detect and quantify aminoacylated and deacylated forms
of tRNAMeti26. As a control, we used aminoacyl-tRNA samples that
were prepared under acidic conditions. Fig. 3C indicates that similar
fractions (∼65%) of tRNAiMet molecules were aminoacylated in both our
WCE preparation (lane 4) and intact aminoacyl tRNA sample (lane 2)
and that Met- tRNAiMet molecules in both the samples were deacylated
completely after treatment with a basic buffer (pH 8.0) (lanes 1 and
3), as previously observed 26. Therefore Met- tRNAiMet deacylation was
not occurring in our cell extracts and would not bias our measurement
of TC abundance.
To exclude the possibility that TC free of MFC easily dissociates
during the immunoprecipitation reaction, we determined TC
levels in the tif5-7A mutant, which alters the eIF5 AA-box 2 and is
known to disrupt MFC formation 8. As mentioned earlier, tif5-7A is a
seven-alanine substitution that likely unfolds C-terminal HEAT-repeat
α-helices of the CTD structure. Fig. 3A, lane 6, shows that this
mutation only partially reduced tRNAMeti co-precipitation from 15 %
to 11% (boxed below second gel, Fig. 3A) compared to FL-eIF2
precipitated (see Fig. 3B for quantification). In contrast, the mutation
substantially reduced the amount of eIF3b precipitated (Fig. 3A-B),
confirming disruption of MFC. Thus, though apparently small, the TC
level determined in Fig. 3 is likely an authentic value.
tRNAiMet

∼40% of eIF2 complexes with eIF5 but lacks MettRNAiMet in vivo
Fig. 3A also indicates that a significantly higher proportion of
eIF2 is associated with eIF5 (1.4 pmol out of 2.5 pmol FL-eIF2
precipitated) than the proportion of eIF2 bound to tRNAiMet (0.42
pmol). This and several other experiments indicated that 54 ± 9 % of
eIF2 is associated with eIF5. Given that TC level is ∼15 % of total eIF2
and that MFC level is smaller than this value, the data implies that
∼40% of eIF2 is present in a binary complex with eIF5 devoid of
tRNAiMet. This was a surprising finding that promoted further
experimentation. To confirm this with a different strain but with the
same technique, we performed a quantitative immunoprecipitation
using yeast strain KAY35 encoding eIF5-FL. We confirmed that ∼60%
of eIF5-FL was associated with eIF2. Of eIF2 that co-precipitated with
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eIF5-FL, only 22 ± 5 % (n = 7) was bound to tRNAiMet (see Fig. 5C,
lane 5, below for a typical example). Thus, the unexpected finding of
eIF5/eIF2 complex lacking tRNAiMet was confirmed in the two
independent assays and likely not an artifact caused by the position of
the tag introduced.

Fig. 5

Comparison of the abundance of eIF2- and eIF5-containing

complexes between cells grown in YPD and SC media.
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(A) Strain KAY128 (FL-SUI3 gcn2Δ; sc eIF5) and its isogenic hc eIF5 derivative
KAY482 (hc eIF5), together with a control strain KAY113 carrying an unmodified SUI3
(C), were grown in YPD (Y) or SC (S) medium and subjected to quantitative
immunoprecipitation, as in Fig. 3A. Immuno-precipitated fractions were analyzed by
Nothern blotting for tRNAiMet (top gel) and immunoblotting for eIF2α (second gel), eIF5
(third gel) and eIF1 (fourth gel) (lanes 6-10), together with 2% of in-put amount
(lanes 1-5). Amount of precipitated proteins per 1 mg WCE is presented below each
gel in pmol. Bottom gel indicates the position and amount of EtBr-stained 5.8S and 5S
rRNA and total tRNA from the same acrylamide gel prior to transfer to a membrane
and Northern hybridization. Note that some tRNA non-specifically coprecipitated with
the 43S particle in lanes 7-10 and obscured specific tRNAiMet precipitation when
examined by EtBr staining alone. (B) The abundance of TC, MFC (left) and total
eIF2/eIF5 complex (right) was quantified from (A) and at least three other
independent experiments as ratio of co-precipitated tRNAiMet, eIF1 and eIF5,
respectively, to total eIF2. (C) Strain KAY35 (gcn2Δ TIF5-FL) and a control strain
KAY113 (C) carrying an unmodified TIF5 were grown in YPD (Y) or SC (S) medium and
subjected to quantitative immunoprecipitation and the results presented exactly as in
Fig. 3A and and4A4A.

To verify the occurrence of a ribosome-free eIF2/eIF5 binary
complex, we resolved the eIF complexes in cell extracts using sucrose
gradient-velocity sedimentation. In these experiments, cycloheximide
was employed to preserve intact ribosomal complexes. As shown in
Fig. 3D, the strain encoding FL-eIF2β contains substantial amounts of
eIF2 and eIF5 in the ribosome-free fractions 1-2. Anti-FLAG
immunoprecipitation of gradient fractions indicates that the majority of
FL-eIF2 precipitated in fractions 1-2 is associated with eIF5 (Fig. 3E,
lanes 1-2). We recently reported a similar gradient analysis using a
strain encoding eIF5-FL and showed that eIF5-FL present in the top,
ribosome-free fractions also co-precipitated with eIF2 and, moreover,
lacked tRNAMeti22. These reciprocal experiments establish the
presence of the novel eIF2/eIF5 complex in the sucrose gradient.
Together with further control experiments on our quantitative
immunoprecipitation that were not reported previously 22, the results
shown in Fig. 3 warrant the authenticity of the eIF complex abundance
values presented in this study.

The level of eIF2/eIF2B complex in vivo
Next, we wished to determine the abundance of the eIF2/eIF2B
complex. As shown in Fig. 3A, nearly all of eIF2B is associated with FLeIF2. The amount of eIF2/eIF2B complex accounts for 7% of eIF2 (see
Fig. 7 for summary). In the sucrose gradient analysis, the majority of
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eIF2B is present in fraction 3 preceding the 43S/48S complex fraction
(Fig. 3D), indicating that the FL-eIF2/eIF2B complex is formed and
migrates more slowly than the 40S ribosome. Furthermore, eIF2Bα
and eIF2Bδ present in ribosome-free fraction 3 co-immunoprecipitated
with anti-FLAG just as efficiently as FL-eIF2 (Fig. 3E), indicating that
nearly all of eIF2B free from the 40S ribosome is associated with eIF2.
These results are consistent with previous immunoprecipitation of
eIF2B with anti-eIF2Bε antibodies, indicating that the nearly entire
eIF2B co-immunoprecipitates with eIF2 and that the eIF2/eIF2B
complex accounts for ∼10% of the total eIF2 27; 28. Thus, as an
enzyme substoichiometric to its substrate, the majority of eIF2B
appears to be fully engaged in the guanine nucleotide exchange
reaction and, consequently, to bind eIF2·GDP or eIF2 alone, prior to
GTP binding. Tight association between eIF2 and eIF2B has been noted
since these factors were discovered in mammals and yeast 29.

The interaction between eIF5 and eIF2 is not affected
by GDP or GMPPNP in vitro
The observation of the binary eIF2/eIF5 complex devoid of
(Fig. 3) suggests that eIF5 can bind eIF2 in vivo even when
the latter is bound to GDP. This idea is consistent with the finding that
eIF5 or its CTD (aa. 241-405) can bind the isolated eIF2β subunit in
the absence of eIF2γ that binds GTP or GDP 8; 30. To test the effect of
guanine nucleotides on the interaction between eIF5 and eIF2 directly,
we allowed GST-eIF5 to bind purified eIF2 in the presence and
absence of 1 mM GDP or GMPPNP, the nonhydrolyzable GTP analogue.
[GMPPNP is used because commercially available GTP is contaminated
with GDP, while GMPPNP is not. The major GMPPNP contaminant is
GTP (∼2%) (Roche).] As shown in Fig. 4, GST-eIF5 or GST-eIF5 (241405) bound to eIF2 with an affinity of KD ∼100 nM in the absence or
presence of the guanine nucleotide used. Thus, the eIF5/eIF2
interaction is not inhibited by GDP nor is it stimulated by GMPPNP.
During the course of this study, Algire et al. showed, without
presenting data, that the affinity of eIF2 for eIF5 in vitro is not altered
by nucleotide or Met-tRNAiMet 11 binding 4. Our results using GSTeIF5-CTD and purified eIF2 also demonstrate that the high affinity of
eIF2 for eIF5 is due to interaction mediated by eIF5-CTD but not due
to its NTD directly involved in the GAP activity. Together, these results
tRNAiMet
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confirm the finding reported by Algire et al. 4 and suggest that an
eIF2·GDP/eIF5 complex can form, at least in vitro.

Fig. 4

The effect of guanine nucleotides on GST-eIF5 binding to purified

eIF2.
Indicated amounts of GST-fusion forms of full-length eIF5 (A, C) or its CTD (aa. 241405) (B) were allowed to bind 20 ng of purified eIF2 in the presence of 1 mM guanine
nucleotides, indicated across the top, and the complex formed was analyzed by GST
pull down, as described previously 51. Bound eIF2 was visualized by immunoblotting
(bottom panels), whereas GST-eIF5 proteins pulled down was visualized by Ponceu S
staining (top panel). Graph to the right shows % of eIF2 bound to GST-fusion proteins
(in panel A and C, average values for eIF2α and eIF2γ bound) plotted against the
concentration of the latter.
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The effect of nutrient change on the abundance of eIFs,
ribosomes, and eIF complexes
The amounts of eIFs and their complexes, as determined in
Figs. 1 and and3,3, were measured with the yeast gcn2Δ strain
KAY128 (Table II) growing exponentially in a complex (undefined) rich
medium YPD (see Materials and Methods) at the doubling time of 1.5
hr. In the synthetic defined medium supplemented with amino acids
(SC), the same cells grew at the doubling time of 2.1 hr. Immunoblot
analyses of WCE prepared from cells grown in YPD and SC media
indicated no significant change in the levels of eIF1, all three eIF2
subunits, all five eIF2B subunits, a, b, g and i subunits of eIF3, eIF5,
and eIF4G1 (data not shown). Sucrose gradient analyses of ribosomes
present in the WCE preparation (not shown) and electrophoretic
analysis of rRNAs isolated from the same preparation (Fig. 5A, bottom
gel, lanes 2-3, for 5S and 5.8S rRNAs) indicated no discernable change
in total ribosome abundance. Interestingly, quantitative
immunoprecipitations revealed that the fraction of FL-eIF2 associated
with Met- tRNAiMet is significantly higher in the SC medium than in the
YPD medium (Fig. 5A, first and second gels). Averaged data from
several independent experiments indicated that the TC abundance was
3 times higher in cells grown in SC medium than in the same cells
grown in YPD medium (Fig. 5B).
We found that the MFC abundance was, on average, unaltered
between cells grown in the YPD versus the SC medium, when
measured by the amount of FL-eIF2 associated with eIF1, one of the
critical MFC components (Fig. 5A, fourth gel, and B). Moreover, the
total abundance of the eIF2/eIF5 complex was not altered (Fig. 5A,
third gel, and B). Because the TC level increased in the SC medium, it
was conceivable that the abundance of a complex between eIF5 and
TC, but lacking other MFC partners was also increased. However, the
amount of tRNAiMet associated with eIF5-FL in a TIF5-FL strain only
marginally increased (by 10±2 %) in the defined SC medium
compared to the complex levels observed in YPD medium (Fig. 5C).
Analysis of eIF1 and eIF3b co-precipitated with eIF5-FL indicated that
the amount of eIF1 bound to eIF5-FL dramatically increased while the
level of eIF5-FL-bound eIF3b did not change (Fig. 5C, third and fourth
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gels). Notably, one third of eIF5-FL is bound to eIF3 in both the
conditions (Fig. 5C, fourth gel). Given that the abundance of eIF3 is
about half of that of eIF5 (Fig. 1 and Table I), the majority (two thirds)
of eIF3 is associated with eIF5 regardless of the growth conditions. In
this context, the significant increase in eIF1 associated with eIF5-FL
observed in the SC medium indicates that nearly all of the eIF3/eIF5
complexes bind eIF1 when the cells are grown in the SC medium. In
conclusion, growth in SC medium significantly increases the
abundance of both TC and eIF1/eIF3/eIF5 complexes, demonstrating
that dynamic changes in eIF intermediate complexes can result from
changes in nutrient availability and/or growth rate. It is noteworthy
that these changes were observed in a gcn2Δ background. Thus, they
are independent of eIF2 phosphorylation and therefore are likely
dependent on other nutrient-sensing pathways (see Discussion).

The effect of Gcn2p expression on the cellular TC level
Gcn2p is known to partially phosphorylate eIF2 when cells are
grown in synthetic defined media 31; 32. Because eIF2
phosphorylation inhibits eIF2B and thereby reduces TC level, Gcn2p
expression in SC medium is expected to lower TC abundance. As
shown in Fig. 6A, we indeed found that Gcn2p expressed from the
p722 plasmid lowered TC level in the strain KAY128 grown in SC
medium (compare lanes 5 and 6). The TC abundance in the presence
of Gcn2p was reduced on average from 50% to 25% compared to total
eIF2 in this medium (Fig. 6B). As a control, eIF2 abundance was not
altered by p722 (data not shown). These results confirm that the
Gcn2p kinase plays a role in downregulating TC abundance in the SC
medium.
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Fig. 6

Gcn2p expression down-regulates TC formation in the SC medium.

(A) Quantitative immunoprecipitation was performed using KAY128 (gcn2Δ FL-SUI3)
transformants carrying an empty vector (gcn2Δ) and p722 (GCN2) and a control
KAY113 (gcn2Δ SUI3) transformant carrying an empty vector, exactly as in Fig. 3A.
The cells were grown in SC-ura medium. (B) TC levels measured from panel (A) and
three other independent experiments with SD in lines.

The eIF2/eIF5 complex downregulates TC formation
Next, we wished to understand the mechanism by which the
growth in the SC medium derepresses TC abundance in the gcn2Δ
strain. One mechanism, suggested by the increase in the level of
eIF1/eIF3/eIF5 complex (Fig. 5C), postulates that the growth in the SC
medium decreases the rate of translation initiation by the ribosome
preinitiation complex without inhibiting eIF2B activity and TC
formation. Reducing the rate of a later step in the initiation pathway
could achieve this and would result in increase in the level of TC and
the eIF1/eIF3/eIF5 complex, both awaiting consumption by actively
initiating ribosomes. An alternative but mutually consistent model
came from our discovery of the eIF2/eIF5 complex free of tRNAiMet and
genetic evidence suggesting that this complex antagonizes TC
formation catalyzed by eIF2B 22. Although we did not observe the
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change in the abundance of the eIF2/eIF5 complex between the two
media tested, the possible modification of the complex by other
signaling pathways was not excluded. To test whether the alteration in
the stability of the eIF2/eIF5 complex is responsible for the high TC
abundance in SC medium in the absence of Gcn2p, we measured TC
levels in the isogenic gcn2Δ strain KAY482 overexpressing eIF5 from a
high-copy (hc) plasmid. hc eIF5 would likely increase the eIF2/eIF5
complex stability by mass action. As expected, hc eIF5 substantially
lowered the TC level in the SC medium with concomitant increase in
the amount of eIF2/eIF5 complex (Fig. 5A and B). These results
support (though do not prove) the model that the novel eIF2/eIF5
complex controls the eIF2B activity to maintain the TC abundance at a
low level. However, because we have not observed any change or
modification made to the eIF2/eIF5 complex, we cannot exclude the
possibility that the suppression observed with hc eIF5 is a bypass of
the normal pathway not involving the regulation of the eIF2/eIF5
complex (see Discussion).

The deduced levels of ribosomal preinitiation complexes
While our methods of cell lysis and immunoprecipitation did not
permit us to examine the ribosomal preinitiation complex levels
directly, our data are largely consistent with the known proportions of
dissociated ribosomal subunits and the level of 43S complex
components. The abundance model summarized in Fig. 7 for yeast
grown in the YPD medium includes the levels of different ribosomal
species (italicized) and their percentage compared to total ribosome
(in parenthesis). We estimate that 7.5% of total eIF2 is present as
MFC (Fig. 3B). If all MFCs bind the dissociated 40S subunit to produce
the 43S complex, ∼2.4% (4700 copies/cell; based on the ribosomal
level of 200,000 copies/cell) of 40S subunits will be found as 43S
complexes. In our polysome profile experiments (such as shown in Fig.
3D, top panel), we consistently observed that ∼10% of ribosomal
subunits are dissociated during yeast grown in the YPD medium (data
not shown). Thus, up to a quarter of dissociated 40S subunits
participate in the 43S complex. It is conceivable that the 40S subunits
free from MFC contain eIF3 alone or its complex with eIF1 and/or eIF5,
depending on their affinity for the ribosome. Indeed, eIF3 abundance
is ∼16% of total ribosome (Table I), consistent with the idea that eIF3
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associates with MFC components off the ribosome in addition to
participating in 43S complex formation. Although we did not measure
eIF1A abundance, von der Haar et al. estimated it at 28% of total eIF2
(Table I, column 4) 16, or ∼9% of total ribosome by our standards (i.
e., eIF2 abundance as one third of ribosome abundance), consistent
with the idea that the majority of eIF1A is bound to dissociated 40S
subunits to set the stage for 43S complex formation and subsequently
regulate 48S complex function 33.

Discussion
Cellular abundance of translation initiation components
and their complexes in S. cerevisiae
In our evaluation of cellular eIF, tRNAiMet and ribosome levels,
we not only confirmed and refined the cellular abundance of individual
eIFs, but also determined the ribosome and Met- tRNAiMet levels in
direct comparison with them. The determined relationship between the
ribosome and eIF levels allowed us to deduce the steady-state
abundance of ribosomal preinitiation complexes (Fig. 7).
During the course of this study, Newman et al. measured the
fluorescence of 4159 GFP-tagged yeast strains 34. Protein fusion to a
large tag like GFP generally changes the protein stability. In addition,
protein complex formation might quench fluorescence from the GFPtag. Indeed, their GFP-eIF abundance values are in general >10 times
lower than our values. The ribosomal protein levels were also
measured for those encoded by two alleles in the genome. The
average for 44 measured small ribosomal proteins (Rps) was 3619 ±
2414 copies/cell, and that for 63 measured large ribosomal proteins
(Rpl) 4329 ± 3406 copies/cell. Of these, Rpl8A and Rpl9B showed the
highest abundance of 17952 and 20074 copies/cell, which are still 10
times lower than the previously established ribosome level 24.
Therefore it seems difficult to determine the absolute abundance of
proteins based solely on a GFP-tagging approach.
Our measurement of eIF2-containing complex abundance
provides insight into the mechanism and control of translation
initiation (Figs. 3, ,55 and and6).6). Our finding that TC and MFC
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represent only ∼15% and ∼8% of total eIF2, respectively, in yeast
actively growing in YPD medium (Fig. 3) supports the idea that TC
formation is a rate-limiting step in translation initiation and that once
formed, TC is rapidly converted into the MFC. However, this was not
the case when yeast were grown less rapidly in SC medium (Fig. 5).
The TC abundance increased 3-fold, while MFC levels were unaltered,
consistent with the reduced growth rate. Thus, TC abundance appears
to be carefully controlled in accordance with nutrient composition
and/or growth rate. Here we investigated two possible mechanisms to
explain these observations (Figs. 5 and and6);6); firstly a role for
Gcn2p activation and secondly via a novel eIF5/eIF2 complex lacking
tRNAiMet, as discussed next.

Fine-tuning of TC abundance by Gcn2p and the novel
eIF2/eIF5 complex
Our finding that TC abundance in a gcn2Δ strain was increased
by three fold in the synthetic defined complete (SC) medium (Fig. 5A)
suggests that eukaryotes possess a mechanism(s) to finely tune the
levels of this critical translation component. As the observed increase
in TC was suppressed by GCN2 expression in the strain (Fig. 6A-B),
the modest eIF2 phosphorylation that had been observed under similar
growth conditions 31; 32 appears to contribute to maintaining a lower
level of TC. Gcn2p is activated by binding of uncharged tRNA that
accumulates during amino acid starvation 35. How Gcn2p is activated
in the presence of abundant amino acids in the medium is unclear. It is
possible that a limited supply of certain critical components regulates a
second nutritional signaling pathway. One such nutrient sensing
pathway known to regulate translation is the TOR kinase pathway 36.
Consistent with this, the inhibition of TOR kinases is shown to activate
Gcn2p in S. cerevisiae37. A second nutrient sensing pathway that
regulates translation is the PAS kinase pathway 38.
A second mechanism to modulate TC abundance was suggested
from our observation that hc eIF5 reverses the TC increase observed
in the absence of Gcn2p (Fig. 5A-B). Although hc eIF5 can perturb
MFC formation by producing partially formed MFC, as proposed
previously 8, this mechanism does not explain the observed decrease
in TC (Fig. 5A-B). Rather, we suggest that hc eIF5 stabilized the
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eIF2/eIF5 complex by mass action, which in turn inhibited eIF2Bcatalized eIF2·GDP recycling and hence TC formation. In our recent
study, we provided ample genetic and biochemical evidence for this
idea using (i) a eIF5-CTD mutation that specifically disrupts eIF2
binding and restores TC decrease caused by hc eIF5 and (ii) eIF2Bε
mutations whose phenotype resulting from reduced TC formation was
exacerbated by hc eIF5 22. The latter results suggest that wild-type
eIF2Bε (the catalytic subunit of eIF2B) is required for eIF2B to outcompete the inhibition by eIF5 bound to its substrate eIF2·GDP,
perhaps by displacing eIF5 from the eIF2/eIF5 complex. Thus, a
second mechanism to maintain the TC abundance homeostasis might
indeed operate via the novel eIF2/eIF5 complex.
In an effort to understand the direct effect of nutrient shift on
the eIF2/eIF5 complex, we carefully measured the abundance of total
eIF2/eIF5 complex and the proportion of TC/eIF5 complex therein.
However, we did not observe a dramatic change in the abundance of
the eIF2/eIF5 complex free of tRNAiMet that would simply explain the
marked difference in TC level (Fig. 5). Instead, we found that most of
the eIF5/eIF3 complex was bound to eIF1 in the SC medium (Fig. 5C).
Moreover, our studies suggest that the TC level increased during
growth in SC medium while free eIF2 (likely GDP-bound) decreased
when compared with YPD-grown cells (Fig. 5). Thus, the activity of
eIF2B in producing eIF2·GTP and hence TC appears to be higher (or
less limiting) in SC medium. The accumulation of an eIF1/eIF3/eIF5
complex in SC medium (Fig. 5C) suggests that translation initiation is
instead suppressed at the level of preinitiation complex function. This
could include MFC interactions, mRNA binding and/or scanning.
A mechanism to explain such regulation postulates that covalent
modification controls eIF2B directly or indirectly by regulating the
inhibitory eIF2/eIF5 complex. A candidate for the effector kinase of
this regulation would be casein kinase 2 (CK2) that phosphorylates
eIF2 in yeast 39, eIF2B in mammals 40, and eIF5 in both yeast and
mammals 41; 42. If eIF2/eIF5 interaction is enhanced by
phosphorylation to promote MFC formation in the YPD medium, the
same modification could increase the stability of the inhibitory
eIF2/eIF5 complex, thereby suppressing the TC abundance. While it is
still unclear whether CK2 activity is regulated 43, yeast CK2 activity is
regulated in a cell cycle-dependent manner, and activated at G1 and
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G2/M phases 44. In humans, CK2-depependent PML protein
degradation is regulated by a MAP kinase 45. Alternatively, control by
one or more phosphatases might be critical for the postulated TC
abundance regulation. It would be interesting to find out if this
regulation via eIF2B or eIF2/eIF5 complex is downstream of the TOR
kinases 36, or relates to the recently identified Gcn2p-indendent
pathway that regulates eIF2B and TC formation 46. Further work is
needed to delineate the Gcn2p-independent pathway(s) that regulate
cellular TC abundance and to determine whether the eIF2/eIF5
complex is a component in this regulation.

Materials and methods
Plasmid construction
Plasmids used in this study are listed in Table III. To produce
the TIF34-FL* allele encoding C-terminally FLAG-tagged eIF3i, the DNA
segment encoding the epitope-tagged TIF34 ORF was amplified by PCR
using oligo 7 (to hybridize to 5′-end of TIF34 ORF) 47 and oligo TIF34FL 5′-CCC AAG GAT CCT TAC TTG TCATCG TCA TCC TTG TAA TCA TTA
GCT TCT TGC ATG TGC TCT TTA GC-3′ (BamHI site and FLAG-coding
region underlined), followed by digestion with EcoRI and BamHI. The
resulting 0.3-kb fragment (3′ fourth of TIF34-FL ORF) was cloned into
the same sites of YCpL-TIF34-Bm 47 to produce YCpTIF34-FL. The
0.5-kb EcoRI-HindIII fragment (3′ fourth of TIF34-FL ORF and its 3′
UTR) of YCpTIF34-FL was cloned into the same sites of pT7-TIF34 47
to create pT7-TIF34-FL. To prepare pET-FL-SUI3, the 1.4-kb NdeIHindIII fragment of YCpSUI3 (FL-SUI3) 8 was cloned into pET23a
(Novagen).
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Table III

Plasmids employed in this study.

The RPL25-FH (or RPL25-FL-His) allele encodes C-terminally
FLAG- and polyhistidine-tagged form of Rpl25p 48. To create pETRPL25-FH, the DNA fragment carrying RPL25-FH was PCR amplified
using oligos RPL25 FW 5′-GGG GCC ATA TGG CTC CAT CTG CTA AGG
CTA CTG CC-3′ and RPL25-RV 5′-GCC CAA GCT TGG ATC CTT AAT GAT
GAT GAT GAT GAT GGC C-3′ (NdeI and HindIII sites underlined) and
pRPL25-FH 48 as template. Its 510-kb NdeI-HindIII fragment was
cloned into pET23a (Novagen).

Yeast strains
Yeast strains encoding epitope-tagged eIFs as the sole source
are listed in Table II. KAY487 was constructed by plasmid shuffling
using transformants of KAY6 (tif34Δ p[URA3 TIF34]) (K. Asano)
carrying YCpTIF34-FL, and 5-fluoroorotic acid as a drug to select
against Ura+ strains 49. The strains used for eIF level determinations
grew like the wild type strains at all the temperatures tested (18°,
22°, 30°, and 37° C), indicating that the tagged alleles are at least
functional in supporting exponential growth in YPD medium.
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Yeast growth media
YPD medium contained 1% (w/v) yeast extract (Difco), 2%
(w/v) bacto peptone (Difco), and 2% (w/v) glucose 50. SC medium is
a synthetic defined medium [0.145% (w/v) yeast nitrogen base w/o
amino acid and ammonium sulfate (Difco), 0.5% (w/v) ammonium
sulfate and 2% (w/v) glucose] supplemented with 0.009% (w/v) of
each 20 amino acids, inositol and uracyl, 0.002% (w/v) adenine, and
0.0009% para-aminobenzoic acid 50. The SC-ura medium is the same
as SC but lacks uracil.

Protein purification
The recombinant forms of FLAG-tagged eIFs or Rpl25p were
purified from BL21(DE3) transformants carrying the corresponding pET
or pT7 derivative plasmids (Table III) using anti-FLAG affinity resin
(Sigma), as described previously 23. Purification of FL-eIF1 was
described previously and the presence of its N-terminal FLAG peptide
sequence was confirmed by peptide sequencing, prior to the
experiment shown in Fig. 2B and C51. Yeast eIF2B was purified from
strain GP3685 as described previously 28.

eIF level determination by epitope-tagging and
immunoblotting
Yeast strains were first grown in 5 ml of the desired medium
overnight at 30 °C. The cells were diluted until A600 = 0.4 into 50 ml of
the same medium, grown for 3-4 hours at 30 °C and then collected at
A600 = 1.5-2.0. Approximately 300-400 μg wet weight of cells were
collected, washed, and resuspended in 250 μl buffer A containing 20
mM Tris-HCl (pH 7.5), 100 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 7 mM
β-mercaptoethanol, 5 mM NaF, 1 mM PMSF, Complete™ protease
inhibitors (Roche), and 1 μg/mL each of pepstain A, leupeptin, and
aprotinin. Resuspended cells were lysed by vortexing with 0.4 g of 0.5
mm glass beads (3 cycles of 30-second vortexing and 30-second
cooling on ice) and cleared by microcentrifugation for 15 mins at
14000 rpm at 4° C. The recovered supernatants were employed as
WCE. The protein concentration of WCE was measured by Bradford
assay (BioRad Protein Assay kit I). 1.25 to 80 μg of total proteins for
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each sample were incubated at 65 °C for 2 mins with Laemmli buffer
[125mM Tris-HCL (pH 6.8), 4% SDS, 25% glycerol, 0.01%
Bromophenol blue] and resolved by 10-20% Tris-Glycine gradient or
7.5% or 12 % uniform gels. The proteins were transferred in Trisglycine transfer buffer for 4-5 hours onto Hybond ECL nitrocellulose
membranes, the immobilized samples were incubated for 1 hour in
PBS + T (PBS + 1% Tween-20) containing 5% non-fat dry milk. The
blots were washed once for 15 minutes and twice for 5 minutes in
PBS+T, and then incubated for 1 hour in PBS+T with mouse
monoclonal anti-HA (diluted 1:2000) or anti-FLAG (diluted 1:500) or
with rabbit polyclonal anti-eIF antibodies. After that, the blots were
directly incubated with horseradish peroxidase-coupled secondary
antibody to mouse or rabbit for 1 hour. Finally the blots were washed
again, and the bands were visualized using the ECL chemiluminescent
system (Amersham Pharmacia), followed by quantification using the
NIHImage software.
In the case of Rpl25p and eIF4G2, the antibodies raised against
these proteins were not available. However, the expression of Rpl25FL is most likely equivalent to the endogenous Rpl25p, because (i) the
protein was expressed from the natural promoter, (ii) Rpl25-FL
precipitated >90% of yeast ribosomes by anti-FLAG affinity resin
without altering its ribosomal protein composition 48 and (iii) no
Rpl25-FL was found free of the ribosome, based on analyses of the
supernatant fractions of the immunoprecipitation reaction or sucrose
gradient polysome fractions of whole cell extracts (WCE) derived from
YIT613 (T. Inada, personal communications).

Determination of TC and other eIF complex levels in
vivo
WCE was prepared from FL-eIF2βor eIF5-FL strains, as
described above. The scale of culture for WCE preparation was usually
100 ml. 1 mg total protein of WCE was employed for
immunoprecipitation with anti-FLAG antibodies in 200 μl of the buffer
A containing RNasin (Promega), as described previously 5, except that
the precipitated proteins on the anti-FLAG affinity resin were washed
in the presence of 50 μM GMPPNP, the nonhydrolyzable GTP analogue.
80 % of the precipitated fraction was used to quantify the amount of
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tRNAiMet in the fraction by a standard protocol 52 with slight
modifications: The RNA sample was extracted with citric acid-saturated
phenol/chloroform/isoamyl alcohol (25:24:1) (pH4.3) (Fisher),
precipitated with 3 volume ethanol, 1/10 volume of 3 M sodium
acetate, and 20 μg of glycogen, and analyzed with purified tRNAiMet as
the standard by 8 % urea PAGE, followed by electro-transfer to
Hybond-XL membrane (Amersham Biosciences) in TBE buffer at 19 V
for 60 min at 4°C, and northern blotting with the 5′-[32P] labeled oligo
probe JA76 5′-AGC CCT GCG CGC TTC CAC TG-3′ specific for tRNAiMet.
The hybridization was done in (0.5 M sodium phosphate, pH7.2, 7%
SDS, and 10 mM EDTA) at 57°C for 20 hr. The membrane was then
washed in 2 X SSPE containing 0.1 % SDS twice, then 1 X SSPE
containing 0.1 % SDS twice, exposed to imaging plate for an
appropriate time, and analyzed by Cyclone™ Storage Phosphor System
(Packard). The reminder of the immunoprecipitated fraction was
analyzed with purified eIF2 (a gift of E. Hannig) as the standard by
SDS-PAGE followed by immunoblotting, as described above.
Molar amounts of tRNAiMet and eIF2 precipitated were
determined directly by comparing the band density against those of
purified components. Molar amounts of other eIFs precipitated were
determined based on the percentage of eIF precipitated and the level
of the corresponding eIFs relative to eIF2. These values are presented
below each gel in Fig. 1A.

Quantitation of aminoacylated tRNAiMet
To measure the relative amount of aminoacylated and
deacylated tRNAiMet in our WCE sample, total RNA was isolated from
WCE by adding them to 4.0 ml AE buffer (0.3 M NaOAc pH 4.5, 10 mM
EDTA), followed by extraction with an equal volume of AE buffersaturated phenol by three rounds of vortex agitation for 1 min with a 1
min incubation on ice between rounds of vortex agitation. After
centrifugation at 3000xg for 15 min at 4°C, the aqueous portion of the
sample was re-extracted by the addition of an equal volume of AE
buffer-saturated phenol and vortex agitation as mentioned above.
After a second centrifugation, the aqueous layer was collected.
precipitated with 3 volume of ethanol and 1/10 volume of 3M sodium
acetate, washed with 70% ethanol and resuspended in a buffer of 10
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mM sodium acetate (pH 4.5) and 1 mM EDTA. Total tRNA sample
containing intact aminoacyl tRNAs was purified in parallel from whole
cells by suspending them directly into 4.0 ml of AE buffer, followed by
phenol extraction and ethanol precipitation. The RNA samples were
separated on a 6.5% acid-urea acrylamide gel exactly as described 26
and transferred to Biodyne B membrane (Pall), followed by
hybridization with radiolabeled probe JA11 (5′TCGGTTTCGATCCGAGGACATCAGGGTTATGA-3′) and phosphorimage
analysis using a Storm 840 (GEhealthcare) as previously described 53.
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Abbreviations
eIF

: eukaryotic initiation factor

TC

: ternary complex

GAP

: GTPase activating protein

G protein : guanine nucleotide binding protein
GEF

: guanine nucleotide exchange factor

CTD

: carboxyl-terminal domain

NTD

: amino-terminal domain

YPD

: yeast-extract peptone dextrose (medium)

SC

: synthetic defined complete (medium)

MFC

: multifactor complex

AA-box

: acidic and aromatic amino acid box

PBS

: phosphate-buffered saline
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GST

: glutathione S-transferase

FH

: FLAG-epitope and polyhistidine double affinity tag

WCE

: whole cell extracts
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